All News #Library
APIs
Praluent® (alirocumab) now approved in EU for cardiovascular disease
18 Mar 2019 //
PR NEWSWIRE
Eylea`s PANORAMA data give fuller view of efficacy in label expansion bid
11 Feb 2019 //
BIOPHARMA DIVE

Market Place
Sourcing Support